Ibuprofen Stadapharm (Ibuprofen)

Ibuprofen Stadapharm, an NSAID, is indicated for conditions involving pain, fever and inflammatory processes.

• Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal aches, and postoperative discomfort.
• Fever: reduces elevated body temperature associated with infections or inflammatory states.
• Osteoarthritis: alleviates joint pain and improves functional mobility in chronic degenerative disease.
• Rheumatoid arthritis: helps control inflammatory joint pain and swelling in autoimmune arthritis.
• Acute inflammation: diminishes swelling and redness in soft‑tissue injuries.

• Ibuprofen Stadapharm exerts its effect by non‑selectively inhibiting cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, which are key in the conversion of arachidonic acid to prostaglandins. By reducing prostaglandin synthesis, it decreases peripheral sensitization of nociceptors, lowers fever set‑point in the hypothalamus, and limits inflammatory edema and leukocyte infiltration at the site of tissue injury.

Adverse reactions to Ibuprofen Stadapharm may vary in frequency and severity.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
• Headache: mild to moderate intensity.
• Dizziness: transient sensation of light‑headedness.
• Rash: mild skin erythema or itching.

Serious or Rare Side Effects

• Gastrointestinal ulceration or bleeding: potentially life‑threatening hemorrhage.
• Renal impairment: acute kidney injury or reduced renal function.
• Severe hypersensitivity: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.

When prescribing Ibuprofen Stadapharm, clinicians should consider several precautionary measures to minimize risk.

• Assess renal function: avoid use in patients with severe renal impairment or dehydration.
• Evaluate gastrointestinal risk: use with caution in individuals with history of ulcers, bleeding or chronic NSAID use.
• Monitor cardiovascular status: limit use in patients with uncontrolled hypertension or known cardiovascular disease.
• Review concomitant medications: avoid concurrent use with other NSAIDs, anticoagulants, or corticosteroids without supervision.
• Pregnancy and lactation: use only if clearly needed and after risk‑benefit assessment by a healthcare professional.
• Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Ibuprofen Stadapharm can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of bleeding.
• Selective COX‑2 inhibitors (e.g., celecoxib): additive gastrointestinal toxicity.
• High‑dose aspirin: heightened renal and gastrointestinal adverse effects.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may reduce antihypertensive effect and impair renal function.
• Diuretics: potential for reduced renal perfusion and electrolyte imbalance.
• Lithium: NSAIDs can increase lithium serum concentrations.
• Methotrexate: decreased clearance leading to toxicity.